Ovarian Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Ovarian Cancer, including details on symptoms, causes, treatment, information.

Volume 2 (2005), Issue 9 (September)

1. Study of etanercept, a tumor necrosis factor-alpha inhibitor, in recurrent ovarian cancer.
   J Clin Oncol, 23(25): 5950-9. [Abstract] [Full-text]
2. Phase I trial of bortezomib and carboplatin in recurrent ovarian or primary peritoneal cancer.
   J Clin Oncol, 23(25): 5943-9. [Abstract] [Full-text]
3. Prognostic importance of preoperative CA-125 in International Federation of Gynecology and Obstetrics stage I epithelial ovarian cancer: an Australian multicenter study.
   J Clin Oncol, 23(25): 5938-42. [Abstract] [Full-text]
4. Transcription factors GATA-4 and GATA-6, and their potential downstream effectors in ovarian germ cell tumors.
   Tumour Biol, 26(5): 265-73. [Abstract] [Full-text]
5. VSGP/F-spondin: a new ovarian cancer marker.
   Tumour Biol, 26(5): 245-57. [Abstract] [Full-text]
6. Microarray comparative genomic hybridization profile of a murine model for epithelial ovarian cancer reveals genomic imbalances resembling human ovarian carcinomas.
   Tumour Biol, 26(5): 236-44. [Abstract] [Full-text]
7. Gemcitabine and carboplatin in second-line ovarian cancer.
   Semin Oncol, 32(4): S4-8. [Abstract] [Full-text]
8. Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer.
   Am J Obstet Gynecol, 193(3): 662-7. [Abstract] [Full-text]
9. Significance of Fas receptor protein expression in epithelial ovarian cancer.
   Hum Pathol, 36(9): 971-6. [Abstract] [Full-text]
10. Proteomics analysis of H-RAS-mediated oncogenic transformation in a genetically defined human ovarian cancer model.
    Oncogene, 24(40): 6174-84. [Abstract] [Full-text]
11. Trends in the incidence and mortality of ovarian cancer in Denmark 1978-2002. Comparison with other Nordic countries.
    Acta Obstet Gynecol Scand, 84(10): 1006-12. [Abstract] [Full-text]
12. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
    J Natl Cancer Inst, 97(18): 1382-4. [Abstract] [Full-text]
13. Polymorphisms in DNA repair genes and epithelial ovarian cancer risk.
    Int J Cancer, 117(4): 611-8. [Abstract] [Full-text]
14. p53 Gene status and response to topotecan-containing chemotherapy in advanced ovarian carcinoma.
    Oncology, 69(2): 154-8. [Abstract] [Full-text]
15. The carboxyl-terminal of BRCA1 is required for subnuclear assembly of RAD51 after treatment with cisplatin but not ionizing radiation in human breast and ovarian cancer cells.
    Biochem Biophys Res Commun, 336(3): 952-60. [Abstract] [Full-text]
16. Cytoplasmic HuR expression correlates with epithelial cancer cell but not with stromal cell cyclooxygenase-2 expression in mucinous ovarian carcinoma.
    Gynecol Oncol, 99(1): 14-9. [Abstract] [Full-text]
17. Primary angiosarcoma of the ovary: a case report of Stage I disease.
    Gynecol Oncol, 99(1): 218-21. [Abstract] [Full-text]
18. Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer.
    Gynecol Oncol, 99(1): 20-5. [Abstract] [Full-text]
19. Adnexal fascioliasis masquerading as ovarian cancer.
    Gynecol Oncol, 99(1): 236-8. [Abstract] [Full-text]
20. The use of an overlay autogenous tissue (OAT) patch to control intra-operative haemorrhage of the spleen.
    Gynecol Oncol, 99(1): 225-7. [Abstract] [Full-text]
21. The effects of Omega-3 fatty acids on growth regulation of epithelial ovarian cancer cell lines.
    Gynecol Oncol, 99(1): 58-64. [Abstract] [Full-text]
22. Implications of second-look laparotomy in the context of optimally resected stage III ovarian cancer: a non-randomized comparison using an explanatory analysis: a Gynecologic Oncology Group study.
    Gynecol Oncol, 99(1): 71-9. [Abstract] [Full-text]
23. Stromal osseous metaplasia in a low-grade ovarian adenocarcinoma.
    Gynecol Oncol, 99(1): 222-4. [Abstract] [Full-text]
24. A-kinase anchoring protein 3 messenger RNA expression correlates with poor prognosis in epithelial ovarian cancer.
    Gynecol Oncol, 99(1): 183-8. [Abstract] [Full-text]
25. Ovarian cancer and venous thromboembolic risk.
    Gynecol Oncol, 99(1): 119-25. [Abstract] [Full-text]
26. Protein expression and prognostic value of genes in the erb-b signaling pathway in advanced ovarian carcinomas.
    Am J Clin Pathol, 124(3): 392-401. [Abstract] [Full-text]
27. Social support, psychological distress, and natural killer cell activity in ovarian cancer.
    J Clin Oncol, 23(28): 7105-13. [Abstract] [Full-text]
28. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.
    J Clin Oncol, 23(28): 6890-8. [Abstract] [Full-text]

© 2004-2008 Ovarian Cancer Research Today. All Rights Reserved.